↓ Skip to main content

Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials

Overview of attention for article published in Pediatric Rheumatology, March 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

policy
1 policy source
twitter
2 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
57 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials
Published in
Pediatric Rheumatology, March 2021
DOI 10.1186/s12969-021-00514-4
Pubmed ID
Authors

Tatjana Welzel, Carolyn Winskill, Nancy Zhang, Andreas Woerner, Marc Pfister

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 57 100%

Demographic breakdown

Readers by professional status Count As %
Lecturer 4 7%
Student > Ph. D. Student 4 7%
Professor 4 7%
Student > Bachelor 4 7%
Researcher 4 7%
Other 13 23%
Unknown 24 42%
Readers by discipline Count As %
Medicine and Dentistry 21 37%
Pharmacology, Toxicology and Pharmaceutical Science 5 9%
Business, Management and Accounting 3 5%
Biochemistry, Genetics and Molecular Biology 1 2%
Agricultural and Biological Sciences 1 2%
Other 1 2%
Unknown 25 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 March 2022.
All research outputs
#6,320,141
of 23,342,232 outputs
Outputs from Pediatric Rheumatology
#236
of 719 outputs
Outputs of similar age
#139,404
of 429,826 outputs
Outputs of similar age from Pediatric Rheumatology
#8
of 33 outputs
Altmetric has tracked 23,342,232 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 719 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,826 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.